Report Detail

Request for Sample of this report

Pharma & Healthcare Global Pembrolizumab Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3557499
    • |
  • 26 June, 2019
    • |
  • Global
    • |
  • 105 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Scope of the Report:
The worldwide market for Pembrolizumab is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Pembrolizumab in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Merck

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
50mg Injection
100mg Injection

Market Segment by Applications, can be divided into
Advanced Melanoma
Head and Neck Squamous Cell Carcinoma (HNSCC)
Unresectable or Metastatic Solid Tumor
Other

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pembrolizumab product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pembrolizumab, with price, sales, revenue and global market share of Pembrolizumab in 2017 and 2018.
Chapter 3, the Pembrolizumab competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pembrolizumab breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Pembrolizumab market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Pembrolizumab sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Pembrolizumab Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 50mg Injection
      • 1.2.2 100mg Injection
    • 1.3 Market Analysis by Applications
      • 1.3.1 Advanced Melanoma
      • 1.3.2 Head and Neck Squamous Cell Carcinoma (HNSCC)
      • 1.3.3 Unresectable or Metastatic Solid Tumor
      • 1.3.4 Other
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Merck
      • 2.1.1 Business Overview
      • 2.1.2 Pembrolizumab Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Merck Pembrolizumab Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Pembrolizumab Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Pembrolizumab Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Pembrolizumab Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Pembrolizumab Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Pembrolizumab Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Pembrolizumab Market Analysis by Regions

    • 4.1 Global Pembrolizumab Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Pembrolizumab Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Pembrolizumab Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Pembrolizumab Sales and Growth Rate (2014-2019)
    • 4.3 Europe Pembrolizumab Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Pembrolizumab Sales and Growth Rate (2014-2019)
    • 4.5 South America Pembrolizumab Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Pembrolizumab Sales and Growth Rate (2014-2019)

    5 North America Pembrolizumab by Country

    • 5.1 North America Pembrolizumab Sales, Revenue and Market Share by Country
      • 5.1.1 North America Pembrolizumab Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Pembrolizumab Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Pembrolizumab Sales and Growth Rate (2014-2019)
    • 5.3 Canada Pembrolizumab Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Pembrolizumab Sales and Growth Rate (2014-2019)

    6 Europe Pembrolizumab by Country

    • 6.1 Europe Pembrolizumab Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Pembrolizumab Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Pembrolizumab Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Pembrolizumab Sales and Growth Rate (2014-2019)
    • 6.3 UK Pembrolizumab Sales and Growth Rate (2014-2019)
    • 6.4 France Pembrolizumab Sales and Growth Rate (2014-2019)
    • 6.5 Russia Pembrolizumab Sales and Growth Rate (2014-2019)
    • 6.6 Italy Pembrolizumab Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Pembrolizumab by Country

    • 7.1 Asia-Pacific Pembrolizumab Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Pembrolizumab Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Pembrolizumab Revenue and Market Share by Country (2014-2019)
    • 7.2 China Pembrolizumab Sales and Growth Rate (2014-2019)
    • 7.3 Japan Pembrolizumab Sales and Growth Rate (2014-2019)
    • 7.4 Korea Pembrolizumab Sales and Growth Rate (2014-2019)
    • 7.5 India Pembrolizumab Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Pembrolizumab Sales and Growth Rate (2014-2019)

    8 South America Pembrolizumab by Country

    • 8.1 South America Pembrolizumab Sales, Revenue and Market Share by Country
      • 8.1.1 South America Pembrolizumab Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Pembrolizumab Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Pembrolizumab Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Pembrolizumab Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Pembrolizumab Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Pembrolizumab by Countries

    • 9.1 Middle East and Africa Pembrolizumab Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Pembrolizumab Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Pembrolizumab Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Pembrolizumab Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Pembrolizumab Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Pembrolizumab Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Pembrolizumab Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Pembrolizumab Sales and Growth Rate (2014-2019)

    10 Global Pembrolizumab Market Segment by Type

    • 10.1 Global Pembrolizumab Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Pembrolizumab Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Pembrolizumab Revenue and Market Share by Type (2014-2019)
    • 10.2 50mg Injection Sales Growth and Price
      • 10.2.1 Global 50mg Injection Sales Growth (2014-2019)
      • 10.2.2 Global 50mg Injection Price (2014-2019)
    • 10.3 100mg Injection Sales Growth and Price
      • 10.3.1 Global 100mg Injection Sales Growth (2014-2019)
      • 10.3.2 Global 100mg Injection Price (2014-2019)

    11 Global Pembrolizumab Market Segment by Application

    • 11.1 Global Pembrolizumab Sales Market Share by Application (2014-2019)
    • 11.2 Advanced Melanoma Sales Growth (2014-2019)
    • 11.3 Head and Neck Squamous Cell Carcinoma (HNSCC) Sales Growth (2014-2019)
    • 11.4 Unresectable or Metastatic Solid Tumor Sales Growth (2014-2019)
    • 11.5 Other Sales Growth (2014-2019)

    12 Pembrolizumab Market Forecast (2019-2024)

    • 12.1 Global Pembrolizumab Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Pembrolizumab Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Pembrolizumab Market Forecast (2019-2024)
      • 12.2.2 Europe Pembrolizumab Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Pembrolizumab Market Forecast (2019-2024)
      • 12.2.4 South America Pembrolizumab Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Pembrolizumab Market Forecast (2019-2024)
    • 12.3 Pembrolizumab Market Forecast by Type (2019-2024)
      • 12.3.1 Global Pembrolizumab Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Pembrolizumab Market Share Forecast by Type (2019-2024)
    • 12.4 Pembrolizumab Market Forecast by Application (2019-2024)
      • 12.4.1 Global Pembrolizumab Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Pembrolizumab Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Pembrolizumab . Industry analysis & Market Report on Pembrolizumab is a syndicated market report, published as Global Pembrolizumab Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Pembrolizumab market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,690.04
      		4,035.06
      		5,380.08
      		3,239.88
      		4,859.82
      		6,479.76
      		531,361.20
      		797,041.80
      		1,062,722.40
      		293,712.00
      		440,568.00
      		587,424.00
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo